Invention Grant
- Patent Title: Humanized antibodies against CXCR3
- Patent Title (中): 针对CXCR3的人源化抗体
-
Application No.: US12449222Application Date: 2008-01-29
-
Publication No.: US08435522B2Publication Date: 2013-05-07
- Inventor: Rodger Smith , Palanisamy Kanakaraj , Viktor Roschke
- Applicant: Rodger Smith , Palanisamy Kanakaraj , Viktor Roschke
- Applicant Address: US MD Rockville
- Assignee: Teva Biopharmaceuticals USA, Inc.
- Current Assignee: Teva Biopharmaceuticals USA, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Foley & Lardner LLP
- International Application: PCT/US2008/052356 WO 20080129
- International Announcement: WO2008/094942 WO 20080807
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K38/17 ; C07K16/18 ; C12N15/63 ; C12P21/04
Abstract:
Disclosed are humanized antibodies that bind specifically to the receptor CXCR3. The humanized antibodies may be antagonists and may be used to treat or diagnose conditions associated with CXCR3 function.
Public/Granted literature
- US20100047238A1 HUMANIZED ANTIBODIES AGAINST Public/Granted day:2010-02-25
Information query
